Lung cancer combo therapy study pulled before it started

NCT ID NCT00210171

Terminated Disease control Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study was designed to test a combination of chemotherapy drugs (cisplatin and docetaxel) with radiation therapy for people with advanced non-small cell lung cancer that could not be removed by surgery. The plan included chemotherapy before, during, and after radiation. However, the study was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cisplatin and docetaxel (chemotherapy drugs)

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA, NON-SMALL-CELL LUNG

Contacts and locations

Locations

Centre Hospitalier Universitaire de Bordeaux

Bordeaux, 33076, France
Centre de radiothérapie d'Agen

Agen, 47000, France
Clinique Francheville

Périgueux, 24000, France
Clinique Tivoli

Bordeaux, 33000, France
Hôpital Robert Boulin

Libourne, 33500, France
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest

Bordeaux, 33076, France
Polyclinique Bordeaux Nord

Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.